Fetal and neonatal alloimmune thrombocytopenia: Prenatal interventions

Prenatal Diagnosis

Volumn 31, Issue 7, 2011, Pages 712-719

  Kamphuis, Marije M ^a   Oepkes, Dick ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fetal and neonatal alloimmune thrombocytopenia; Fetal therapy; Intracranial haemorrhage; Intravenous immunoglobulins

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; HLA DR ANTIGEN; HLA DRB3 ANTIGEN; HUMAN PLATELET ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LEUKOCYTE ANTIGEN; PREDNISONE; STEROID; UNCLASSIFIED DRUG;

ADD ON THERAPY; ASEPTIC MENINGITIS; BRADYCARDIA; BRAIN DAMAGE; BRAIN HEMORRHAGE; CESAREAN SECTION; CLINICAL EFFECTIVENESS; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EXSANGUINATION; FETUS BLOOD SAMPLING; HIGH RISK INFANT; HIGH RISK PREGNANCY; HUMAN; IMMUNOMODULATION; INFECTION; INTERMETHOD COMPARISON; INTRAUTERINE BLOOD TRANSFUSION; INVASIVE PROCEDURE; KIDNEY FAILURE; LARYNX EDEMA; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NON INVASIVE PROCEDURE; OLIGOHYDRAMNIOS; PATHOPHYSIOLOGY; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOSIS; TREATMENT RESPONSE; VIRUS INFECTION;

ALGORITHMS; BLOOD SPECIMEN COLLECTION; FEMALE; FETAL DISEASES; FETAL THERAPIES; HUMANS; INFANT, NEWBORN; PLATELET TRANSFUSION; PREGNANCY; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 79959352010     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2779     Document Type: Review

References (53)

1. Berkowitz RL, Kolb EA, McFarland JG, et al. 2006. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 107: 91-96.
2. Berkowitz RL, Lesser ML, McFarland JG, et al. 2007. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial. Obstet Gynecol 110: 249-255.
3. Bertrand G, Drame M, Martageix C, Kaplan C. 2011. Prediction of the fetal status in non-invasive management of alloimmune thrombocytopenia. Blood 117: 3209-3213.
4. Birchall JE, Murphy MF, Kaplan C, Kroll H. 2003. European Fetomaternal Alloimmune Thrombocytopenia Study Group. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol 122: 275-288.
5. Blanchette VS, Johnson J, Rand M. 2000. The management of alloimmune neonatal thrombocytopenia. Am J Perinatol 5: 365-390.
6. Bussel JB, Primiani A. 2008. Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates. Blood Rev 22: 33-52.
7. Bussel JB, Berkowitz RL, Hung C, et al. 2010. Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol 203: 135.e1-14.
8. Bussel JB, Berkowitz RL, Lynch L, et al. 1996. Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gammaglobulin. Am J Obstet Gynecol 174: 1414-1423.
9. Bussel JB, Berkowitz RL, McFarland JG, et al. 1988. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 319: 1374-1378.
10. Bussel J, Kaplan C, Mc Farland J. 1991. Recommendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia. The Working Party on Neonatal and Hemostasis Subcommittee of the Scientific and Standardization Committe of the ISTH. Thromb Haemost 65: 631-634.
11. Daffos F, Forestier F, Muller JY, et al. 1984. Prenatal treatment of alloimmune thrombocytopenia. Lancet 2(8403): 632.
12. Ghevaert C, Campbell K, Stafford P, et al. 2007. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia. Transfusion 47: 1296-1305.
13. Giers G, Wenzel F, Stockschlader M, et al. 2010. Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobin infusions. Haematologica 95: 1921-1926.
14. Husebekk A, Killie MK, Kjeldsen-Kragh J, Skogen B. 2009. Is it time to implement HPA-1 screening in pregnancy? Curr Opin Hematol 16: 497-502.
15. Kamphuis MM, Paridaans N, Porcelijn L, et al. 2010. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. BJOG 117: 1335-1343.
16. Kanhai HH, van den Akker ES, Walther FJ, Brand A. 2006. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage. Fetal Diagn Ther 21: 55-60.
17. Kaplan C. 2002. Platelet alloimmunity: the fetal/neonatal alloimmune thrombocytopenia. Vox Sang 83: 289-291.
18. Kaplan C, Daffos F, Forestier F, et al. 1988. Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood 72: 340-343.
19. Kiefel V, Bassler D, Kroll H, et al. 2006. Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood 109: 388-389.
20. Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B. 2008. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 93: 870-877.
21. Kjeldsen-Kragh J, Killie MK, Tomter G, et al. 2007. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 110: 833-839.
22. Knight M, Pierce M, Allen D, et al. 2011. The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources. Br J Haematol 152: 460-468.
23. Kroll H, Kiefel V, Giers G, et al. 1994. Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia. Transfus Med 4: 293-296.
24. Looney CB, Smith JK, Merck LH, et al. 2007. Intracranial hemorrhage in asymptomatic neonates: prevalence on MR images and relationship to obstetric and neonatal risk factors. Radiology 242: 535-541.
25. Lynch L, Bussel J, Goldberg JD, et al. 1988. The in utero diagnosis and management of alloimmune thrombocytopenia. Prenat Diagn 8: 329-331.
26. Lynch L, Bussel JB, McFarland JG, et al. 1992. Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol 80: 67-71.
27. Mueller-Eckhardt C, Kiefel V, Grubert A, et al. 1989. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1: 368-366.
28. Ni H, Chen P, Spring CM, et al. 2006. A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood 107: 2976-2983.
29. Nicolini U, Rodeck CH, Kochenour NK, et al. 1988. In-utero platelet transfusion for alloimmune thrombocytopenia. Lancet 2(8609): 506-506.
30. Nicolini U, Tannirandorn Y, Gonzalez P, et al. 1990. Continuing controversy in alloimmune thrombocytopenia: fetal hyperimmunoglobulinemia fails to prevent thrombocytopenia. Am J Obstet Gynecol 163: 1144-1146.
31. Overton TG, Duncan KR, Jolly M, et al. 2002. Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome. Am J Obstet Gynecol 186: 826-831.
32. Paidas MJ, Berkowitz RL, Lynch L, et al. 1995. Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. Am J Obstet Gynecol 172: 475-479.
33. Pearson HA, Shulman NR, Marder VJ, Cone TE Jr. 1964. Isoimmune neonatal thrombocytopenic purpura. Clinical and therapeutic considerations. Blood 23: 154-177.
34. Porcelijn L, Van den Akker ES, Oepkes D. 2008. Fetal thrombocytopenia. Semin Fetal Neonatal Med 13: 223-230.
35. Radder CM, de Haan MJJ, Brand A, et al. 2004a. Follow up of children after antenatal treatment for alloimmune thrombocytopenia. Early Hum Dev 80: 65-76.
36. Radder CM, Kanhai HH, Brand A. 2004b. On the mechanism of high dose maternal intravenous immunoglobulin (IVIG) in alloimmune thrombocytopenia. In: Radder CM (thesis). Management of Fetal Alloimmune Thrombocytopenia. Print Partners Ipskamp: Amsterdam; 69-81.
37. Rayment R, Brunskill SJ, Soothill PW, Roberts DJ, Bussel JB, Murphy MF. 2011. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev 5: CD004226.
38. Rooks VJ, Eaton JP, Ruess L, et al. 2008. Prevalence and evolution of intracranial hemorrhage in asymptomatic term infants. Am J Neuroradiol 29: 1082-1089.
39. Sainio S, Teramo K, Kekomäki R. 1999. Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia. Transfus Med 9: 321-330.
40. Spencer JA, Burrows RF. 2001. Feto maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynecol 41: 45-55.
41. te Pas AB, Lopriore E, van den Akker ES, et al. 2007. Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG. Eur J Pediatr 166: 1057-1063.
42. Thung SF, Grobman WA. 2005. The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 193: 1094-1099.
43. Turner ML, Bessos H, Fagge T, et al. 2005. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 45: 1945-1956.
44. Urbaniak SJ, Duncan JI, Armstrong-Fisher SS, et al. 1999. Variable inhibition of placental IgG transfer in vitro with commercial IVgG preparations. Br J Haematol 107: 815-817.
45. Van den Akker ES, Oepkes D. 2008. Fetal and neonatal alloimmune thrombocytopenia. Best Pract Res Clin Obstet Gynaecol 22: 3-14.
46. Van den Akker ES, Oepkes D, Brand A, Kanhai HH. 2006. Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia? BJOG 113: 781-783.
47. Van den Akker ES, Oepkes D, Lopriore E, et al. 2007. Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective. BJOG 114: 469-473.
48. Van Gils JM, Stutterheim J, van Duijn TJ, et al. 2009. HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity. Mol Immunol 46: 406-415.
49. Van Kamp IL, Klumper FJ, Oepkes D, et al. 2005. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 192: 171-177.
50. Vinograd CA, Bussel JB. 2010. Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective. Haematologica 95: 1807-1811.
51. Warwick RM, Vaughan J, Murray N, Lubenko A, Roberts I. 1994. In vitro culture of colony forming unit-megakaryocyte (CFU-MK) in fetal alloimmune thrombocytopenia. Br J Haematol 88: 874-877.
52. Williamson LM, Hackett G, Rennie J, et al. 1998. The natural history of fetomaternal alloimmunization to the platelet specific antigen HPA-1a (PIAý, Zwa) as determined by antenatal screening. Blood 92: 2280-2287.
53. Yinon Y, Spira M, Solomon O, et al. 2006. Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage. Am J Obstet Gynecol 195: 1153-1157.